Exemples de Réussite May 02, 2024 Comment BeiGene favorise l’accès au traitement du cancer à l’échelle mondiale Depuis son siège européen à Bâle, en Suisse, BeiGene collabore de manière stratégique avec des parties prenantes dans le monde entier pour f...
News Apr 30, 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Success stories Apr 23, 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
News Nov 17, 2023 Geistlich Pharma launches new education program Geistlich Pharma is launching the Geistlich myGuide education program with a focus on dentistry and regenerative dentistry. The scientific partne...
News Mar 28, 2024 Avallain agrees takeover of TeacherMatic Avallain has acquired the London-based firm TeacherMatic. With this takeover, the software specialist for education applications intends to expan...
News Mar 08, 2024 VirtaMed and Atracsys announce collaboration VirtaMed and Atracsys are joining forces to drive innovation in medical training and simulation. The partners are focusing on robot-assisted and ...
News Feb 29, 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Success stories Apr 04, 2024 Snake venum for the Spanish pharma industry Pentapharm, a science-based company located in the Basel area, is a leading international supplier of high-quality biochemical materials for vari...
News Feb 14, 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Actualités Mar 06, 2023 Mindmaze lance son dispositif révolutionnaire pour la rééducation motrice après un AVC MindMaze, leader mondial vaudois de la neurothérapie numérique alimentée par l’IA, a lancé Izar, son dispositif médical propriétaire, aux États-U...
Aktuell Nov 17, 2023 Geistlich Pharma lanciert neues Bildungsangebot Geistlich Pharma lanciert das Bildungsangebot Geistlich myGuide für den Bereich der Dentalmedizin und insbesondere der dentalen Regeneration. Wis...
News Jan 10, 2024 Using AI technology to identify unique chemical signatures of prestigious wines A team from the University of Geneva, in partnership with the University of Bordeaux, has achieved a significant breakthrough in wine science. Us...
News Jan 04, 2024 Lucerne University of Applied Sciences and Arts to teach nursing at degree level Lucerne University of Applied Sciences and Arts will begin teaching degree-level nursing from the 2024 fall semester. It is also expanding its pr...
News Dec 06, 2023 EPFL’s new AI Center to pioneer AI research and collaboration in Switzerland The Ecole Polytechnique Fédérale de Lausanne (EPFL) has launched its new AI Center. This new hub is dedicated to exploring how safe and effective...
News Dec 04, 2023 Bern University of Applied Sciences launches the Institute for Patient-Centered Digital Health The Bern University of Applied Sciences is set to enhance its foothold in medical informatics with the establishment of a new institute dedicated...
News Nov 29, 2023 Meditron, EPFL’s new Large Language Model for medical knowledge EPFL researchers have unveiled Meditron, a groundbreaking open-source Large Language Model (LLM) specifically tailored for the medical field.
News Dec 01, 2023 HSLU becomes first Swiss university to offer immersive technologies course Lucerne University of Applied Sciences and Arts (HSLU) will be the first Swiss university to offer an undergraduate degree program in immersive t...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...